[1] 苏懿,王磊,张敏州.急性心肌梗死的流行病学研究进展[J].中西医结合心脑血管病杂志,2012,10(4):467~469. [2] 刘卫其,张励庭,黄炫生,等.急性ST段抬高型心肌梗死的急诊介入治疗与择期介入治疗预后对比[J].中国动脉硬化杂志,2011,19(9):781~784. [3] 李守凯,张爱萍,段玉柱.非ST段抬高型心肌梗死与ST段抬高型心肌梗死的临床特征[J].中国老年学,2012,32(21):4783~4784. [4] Zhang J H,Yuan J Q,Meng X M,et al.Abstract 18093:bleeding events in clopidogrel-treated patients with STEMI is associated with a genetic risk score based on high-risk genetic polymorphisms[J].Circulation,2014,130:A18093~A18093. [5] 王义梅,曹婉燕,刘贵昌.氯吡格雷、阿斯匹林与低分子肝素联合治疗ST段抬高型心肌梗死疗效观察[J].中国医疗前沿,2010,5(16):3~5. [6] 中华医学会心血管病学分会.急性ST段抬高型心肌梗死诊断和治疗指南[J].中华心血管病杂志,2010,43(8):675. [7] 马路,杨晔.《2013年美国急性ST段抬高型心肌梗死的处理指南》解读[J].中华老年心脑血管病杂志,2013,15(8):891~894. [8] Suryadevara R,Steinhubl S R.Is a higher loading dose of clopidogrel more effective during primary angioplasty for patients with STEMI[J].Interventional Cardiology,2012,4(1):45~48. [9] 张新梅,胡允兆,陈样新,等.急性心肌梗死住院死亡危险因素分析[J].广东医学,2013,34(2):260~263. [10] Prech M,Bartela E,Araszkiewicz A,et al.Limited efficacy of on-table administration of Gp IIb/IIIa inhibitors in STEMI patients pre-treated with 600 mg of clopidogrel[J].World Congress of Cardiology Scientific Sessions.2012:E855~E855. [11] 刘瑞萍.静脉溶栓对急性心肌梗死治疗效果的多因素分析[J].中国医药指南,2013,27(13):2201~2203. [12] 许文举,林艳足,庄丽,等.氯吡格雷联合阿司匹林治疗急性心肌梗死的疗效[J].中外医疗,2013,33(28):1665~1666.
2017, Vol. 23 
冀公网安备13080202000677号